Merrimack Pharmaceuticals
MACK
$21.62
Share price
0.00%
Change (1 day)
8.15%
Change (1 year)
Categories
Merrimack Pharmaceuticals (MACK) - Total assets
Total assets on the balance sheet as of March 2024 : C$0.34 Billion
According to Merrimack Pharmaceuticals's latest financial reports the company's total assets are C$0.34 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Merrimack Pharmaceuticals - Total assets on balance sheet (from 2010 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | C$25.45 M | -5.45% |
| 2022-12-31 | C$26.91 M | 43.2% |
| 2021-12-31 | C$18.79 M | -12.13% |
| 2020-12-31 | C$21.39 M | -18.44% |
| 2019-12-31 | C$26.22 M | -78.25% |
| 2018-12-31 | C$0.12 B | -18.23% |
| 2017-12-31 | C$0.14 B | 34.71% |
| 2016-12-31 | C$0.10 B | -66.39% |
| 2015-12-31 | C$0.32 B | 77.13% |
| 2014-12-31 | C$0.18 B | -10.2% |
| 2013-12-31 | C$0.20 B | 38.27% |
| 2012-12-31 | C$0.14 B | 70.73% |
| 2011-12-31 | C$86.76 M | 50.76% |
| 2010-12-31 | C$57.55 M | -33.42% |
| 2009-12-31 | C$86.44 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 | C$197.46 B | 56,461.42% | 🇫🇷 France |
 | C$0.14 B | -58.57% | 🇺🇸 USA |
 | C$0.84 B | 143.03% | 🇺🇸 USA |
 | C$0.49 B | 41.93% | 🇺🇸 USA |
 | C$7.52 M | -97.84% | 🇺🇸 USA |